🇺🇸 FDA
Patent

US 10894065

Methods for production of platelets from pluripotent stem cells and compositions thereof

granted A61KA61K35/19A61P

Quick answer

US patent 10894065 (Methods for production of platelets from pluripotent stem cells and compositions thereof) held by Astellas Institute for Regenerative Medicine expires Mon Jan 14 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Astellas Institute for Regenerative Medicine
Grant date
Tue Jan 19 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 14 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
8
CPC classes
A61K, A61K35/19, A61P, A61P17/02, A61P33/06